Battle gets fiercer over Cozaar generic Market

Published: 2008-12-19 06:59:00

Updated: 2008-12-19 06:59:00

Major pharmaceutical companies have waged fiercer campaigns to raise market share of their Cozaar (losartan potassium) generics amid stronger competition.

Dong-A, Yuhan, Hanmi and Chong Kun Dang started aggressive marketing to increase their cash cows.

Market experts said competition will b...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK